OUR QUALITY POLICY

As a quality conscious organisation we are committed to meet or even exceed our customer’s expectations by maintaining high standards in all our activities, services, products and processes.

Our quality control group is involved throughout the entire development process, from drug substance and raw material control, through intermediate drug product testing, to finished drug product release testing and stability studies. This group implements the principles of “Quality by Design” (QBD) and “Design of Experiments” at all aspects.

Our research facility and manufacturing sites are fully compliant with cGMP requirements and house a number of new technological solutions. This allows us to assist our partners in the development of challenging and value added products for the global market. Our permanent improvement program includes continuous investments in ultramodern equipment and extensive training of our personnel.